What We Do

NASTAD's programmatic teams interpret and influence policies, conduct trainings, offer technical assistance, and provide advocacy mobilization for U.S. health departments to improve health outcomes for people living with HIV and hepatitis. Read about the teams and their initiatives below.


Drug User Health

NASTAD's Drug User Health team produces resources, provides TA to our members and community-based harm reduction programs, and advocates for an effective science-based public health approach to address the needs of people who inject drugs.

Health Care Access

NASTAD's Health Care Access team supports state and territorial health department HIV programs implement comprehensive and equity-centered state-of-the-art medical care, treatment, and support services to all people living with HIV/AIDS.

Health Equity

The vision of the Health Equity team is to dismantle systemic barriers and shift power dynamics by emphasizing the historical context through which our system operates and centering communities in order to produce measurable changes and support everyone in leading healthier lives.

Health Systems Integration

NASTAD's Health Systems Integration team aims to bridge public health and health care systems to ensure that all systems and payers are effective partners in ending the HIV and hepatitis epidemics. 



NASTAD's Hepatitis team provides guidance and technical assistance to strengthen the capacity of state and local health departments to develop, maintain and enhance comprehensive hepatitis programs as they address the continuum from prevention through cure.

HIV Prevention

NASTAD’s diverse HIV prevention team collaborates across all of NASTAD’s programs to comprehensively address the goal of ending the intersecting epidemics of HIV and related conditions. 

Policy & Legislative Affairs

NASTAD’s Policy and Legislative Affairs program leads the implementation of NASTAD’s legislative and policy priorities on federal appropriations and legislation related to HIV and hepatitis prevention, care, and treatment issues.